Catalyst
Slingshot members are tracking this event:
Alnylam to File an IND for ALN-HBV in early 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALNY | Community voting in process | |||||
Additional Information
With our Hepatic Infectious Disease STAr, we filed our CTA and received approval for ALN-HPV to start our Phase I study, and we anticipate doing so mid-year.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2017
Occurred Source:
http://files.shareholder.com/downloads/ABEA-430HSO/3263093277x0x923329/DEE75FED-1362-4F86-9EFF-B71D1666EC64/ALNY-JPM-PRESENTATION.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Investigational New Drug, Aln-hbv
